1 Min Read
Feb 5 (Reuters) - Invictus Md Strategies Corp:
* INVICTUS MD STRATEGIES CORP - SALES LICENSE FOR ACREAGE PHARMS IS EXPECTED TO OCCUR IN Q1 OF 2018 Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.